Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 11.3414.7129.3720.808.85

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80
Mar20208.85

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8
135.03
Mar2020 8.85 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹314.4 Cr 5.6% 5.9% -18.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,293.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹139,692.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹111,807.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,404.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹90,843.0 Cr -3% -0.9% -7.7% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

5.6%

5.9%

-18.1%

SENSEX

-5.5%

0.2%

-1%


You may also like the below Video Courses